# Digital Integrated Healthcare Platform in Patients With Type 2 Diabetes

Study · id `cardio:ct-nct04161170` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04161170](<https://clinicaltrials.gov/study/NCT04161170>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04161170

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 294 participants.

## Technical summary

Registry record NCT04161170. Randomized; no masking; primary purpose treatment. Start 2019-11-20 (actual); primary completion 2021-08-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 294 participants (planned count; ClinicalTrials.gov record NCT04161170, source copy `cardio:ctgov-nct04161170-2020-01-18`, retrieved 2026-10-26)
- Started: 2019-11-20 (actual) (ClinicalTrials.gov record NCT04161170, source copy `cardio:ctgov-nct04161170-2020-01-18`, retrieved 2026-10-26)
- Primary completion: 2021-08-31 (anticipated) (ClinicalTrials.gov record NCT04161170, source copy `cardio:ctgov-nct04161170-2020-01-18`, retrieved 2026-10-26)
- Completion: 2021-12-31 (anticipated) (ClinicalTrials.gov record NCT04161170, source copy `cardio:ctgov-nct04161170-2020-01-18`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT04161170, source copy `cardio:ctgov-nct04161170-2020-01-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04161170-2020-01-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Digital Integrated Healthcare Platform in Patients With Type 2 Diabetes
- Condition: Type 2 Diabetes
- Intervention (Device): Digital integrated healthcare platform
- Lead sponsor: Samsung Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Samsung Medical Center (`cardio:org-samsung-medical-center`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial (`cardio:pubmed-36821833`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 73c0a8c7917294f744a78f37b0d9802c9f5432658d79ffd30d8335fad5c6b7ec
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
